LOADING
Tag: Disease
Lebrikizumab plus TCS shows sustained disease control in refractory atopic dermatitis – Hospital Healthcare Europe
December 10, 2025
Lebrikizumab plus TCS shows sustained disease control in refractory atopic dermatitis Hospital Healthcare Europe Source link
chat_bubble0 Comment
visibility6 Views
Kymera’s STAT6 Degrader for Inflammatory Disease Shows Early Success in Phase I – Genetic Engineering and Biotechnology News
June 3, 2025
Kymera’s STAT6 Degrader for Inflammatory Disease Shows Early Success in Phase I Genetic Engineering and Biotechnology News Source link
chat_bubble0 Comment
visibility63 Views
Prolonged Delgocitinib Use and Disease Control in Hand Eczema – Physician's Weekly
March 17, 2025
Prolonged Delgocitinib Use and Disease Control in Hand Eczema Physician’s Weekly Source link
chat_bubble0 Comment
visibility89 Views
New Analysis of Organon’s VTAMA® (tapinarof) cream, 1% Phase 3 Data Shows Atopic Dermatitis Disease Activity Remained Low After Treatment-Free Interval in Adults and Children 2 Years of Age and Older – Business Wire
March 9, 2025
New Analysis of Organon’s VTAMA® (tapinarof) cream, 1% Phase 3 Data Shows Atopic Dermatitis Disease Activity Remained Low After Treatment-Free Interval in Adults and Children 2 Years of Age and Older Business Wire Source link
chat_bubble0 Comment
visibility107 Views